Home › Lipoid Nephrosis › New York
Lipoid Nephrosis clinical trials in New York
6 studies for Lipoid Nephrosis are looking for participants at sites in New York.
Cities in New York
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Columbia University Irving Medical Center- Site Number : 8400001, New York
- The Children's Hospital at Montefiore- Site Number : 8400027, The Bronx
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702Nephrotic Syndrome Study Network
- Cohen Children's Hospital, New Hyde Park
- New York University Medical Center, New York
- Bellevue Hospital, New York
- and 3 more
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000NEPTUNE Match Study
- Northwell/Cohen's Children's Hospital, New Hyde Park
- Columbia University Medical Center, New York
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cohen Children's Medical Center, New Hyde Park
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)
- Cohen Children's Medical Center, New Hyde Park
Recruiting
Ages 3 to 17 · All sexes · Updated Apr 17, 2026 · NCT05583942taVNS for FRNS in Children
- Cohen Children's Medical Center, New Hyde Park
Recruiting
Ages 3 to 17 · All sexes · Updated Apr 15, 2026 · NCT05588063From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.